NCT03345147

Brief Summary

The goal of this study is to assess whether 3-5 years-old children who have Vitamin A intakes above the tolerable upper intake level (UL=900 ug per day) have higher total body Vitamin A stores and biomarkers of excessive vitamin A status, compared to children with Normal Vitamin A intakes (250-600 ug per day).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
178

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 13, 2017

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2017

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2017

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 17, 2017

Completed
Last Updated

November 17, 2017

Status Verified

November 1, 2017

Enrollment Period

8 months

First QC Date

August 25, 2017

Last Update Submit

November 13, 2017

Conditions

Keywords

Vitamin AIsotopic dilutiondietary assessment

Outcome Measures

Primary Outcomes (2)

  • Total Vitamin A stores among 3-5 years-old children, in micromoles

    Estimated using Carbon 13 (13C) 13C-retinol dilution method, by the ratio of Labelled (stable isotope) versus no labelled Vitamin A in plasma 4 days after dose of labelled VA is given.

    28-day study period

  • Total dietary vitamin A intake among 3-5 years-old children, in micrograms (ug)

    Estimated using 24-hour dietary recalls, observed weigh food records, food and supplement frequency questionnaire

    28-day study period

Secondary Outcomes (9)

  • Plasma retinol among 3-5 years-old children

    28-day study period

  • Plasma retinol binding protein among 3-5 years-old children

    28-day study period

  • Plasma Transthyretin among 3-5 years-old children

    28-day study period

  • Bone Health markers among 3-5 years-old children

    28-day study period

  • Liver function markers among 3-5 years-old children

    28-day study period

  • +4 more secondary outcomes

Other Outcomes (5)

  • Hemoglobin concentration in children

    At recruitment

  • Children weight and length

    At recruitment

  • Systemic inflammation in children

    At recruitment

  • +2 more other outcomes

Study Arms (2)

Normal Vitamin A intake

Normal Vitamin A intake will be assessed by a questionnaire directed to the consumption of food items with high VA content on the 7 days prior to the questionnaire. The daily consumption will be assessed on average. A child is assigned to Normal Vit. A consumption if daily Vit. A is between 250 and 600 micrograms per day.

Other: Normal Vitamin A intake

High Vitamin A intake

High Vitamin A intake will be assessed by a questionnaire directed to the consumption of food items with high VA content on the 7 days prior to the questionnaire. The daily consumption will be assessed on average. A child is assigned to High Vit. A consumption if daily Vit. A is above 900 micrograms per day.

Other: High Vitamin A intake

Interventions

Total Vitamin A stores will be assessed by isotopic measurement, 13C-Retinol will be given to the subject and blood wil be drawn on Day 4 to assess the isotopic dilution in the plasma. Other biochemical indicators will be assessed too, along with Dietary assessment (Food Frequency, 24 hours recalls).

High Vitamin A intake

Total Vitamin A stores will be assessed by isotopic measurement, 13C-Retinol will be given to the subject and blood wil be drawn on Day 4 to assess the isotopic dilution in the plasma. Other biochemical indicators will be assessed too, along with Dietary assessment (Food Frequency, 24 hours recalls).

Normal Vitamin A intake

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children and Women from Guatemala peri-urban areas or areas where High Vitamin A foods intake is reported. Convenience sampling according to the availability (time to participate in the study) of the participant, and acceptance of Blood sampling and Dietary assessments

You may qualify if:

  • Children 3-5 years old and their mothers
  • Child VA intake must be above 250 micrograms/day
  • Children must be apparently healthy, Hemoglobin\>9 g/dL at recruitment point, C-reactive protein\<5 mg/L. For Women, Hemoglobin\>10 g/dL, C-reactive protein\<5 mg/L

You may not qualify if:

  • °Children with Congenital or chronical diseases, reported illnesses 1 week before the test. For Women: Pregnancy or lactation, Previously known Chronic Diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Mixco, La Comunidad City Hall

Guatemala City, Guatemala

Location

Sacatepequez City Hall

Guatemala City, Guatemala

Location

Santa Catarina Pinula City Hall

Guatemala City, Guatemala

Location

Related Publications (1)

  • Ford JL, Green JB, Haskell MJ, Ahmad SM, Mazariegos Cordero DI, Oxley A, Engle-Stone R, Lietz G, Green MH. Use of Model-Based Compartmental Analysis and a Super-Child Design to Study Whole-Body Retinol Kinetics and Vitamin A Total Body Stores in Children from 3 Lower-Income Countries. J Nutr. 2020 Feb 1;150(2):411-418. doi: 10.1093/jn/nxz225.

Biospecimen

Retention: SAMPLES WITH DNA

Venous blood will be drawn on Day 4 post C-13 Vitamin A administration (women and children) and one variable day (children only) to obtain plasma, serum, and buffy coat (Day 4), or only plasma on variable day post Vitamin A dose for children.

Study Officials

  • Dora I Mazariegos, MsSc

    Institute of Nutrition of Central America and Panama

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher, Nutritional Biochemistry Laboratory

Study Record Dates

First Submitted

August 25, 2017

First Posted

November 17, 2017

Study Start

January 13, 2017

Primary Completion

September 13, 2017

Study Completion

October 30, 2017

Last Updated

November 17, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will share

All Collected individual participant data (IPD) will be shared within the researchers group of the Global Project (GLOVITAS, leaded by Newcastle University). Only initials will identify individual participants and the information shared will be on biochemical markers, diet, and general socioeconomic data.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
Data will become available when, after study data collection is finished, data are cleaned and analyzed.
Access Criteria
All pre-defined researchers will have access to database. This includes Georg Lietz, principal coordinator, and local Principal researchers.
More information

Locations